Italy-based medical device company Sorin Group also has an option to acquire the US-based heart treatment company.
Italy-based medical device company Sorin Group has invested $8m in US-based heart treatment company Cardiosolutions on Tuesday.
Sorin also has an option to acquire the company in the future. Sorin joins venture firms STD Med and BioVentures Investors as an investor in Cardiosolutions.
Andre-Michel Ballester, chief executive of Sorin Group, said: “Mitral valve disease is significantly undertreated in the world today and patients are looking for less invasive therapies to address this problem. The investment in Cardiosolutions confirms Sorin’s commitment…
